/Becton%20Dickinson%20%26%20Co_%20logo%20on%20phone-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market cap of $68.8 billion, Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a leading global medical technology firm. It develops and supplies medical devices, diagnostic products, and lab equipment globally, focusing on improving medication delivery, diagnostics, and interventional care. BDX is expected to release its fiscal Q4 earnings results before the market opens on Thursday, Nov. 7.
Ahead of this event, analysts expect the medical device manufacturer to report a profit of $3.77 per share, marking an increase of 10.2% from $3.42 per share in the same quarter last year. The company has consistently exceeded or met Wall Street's earnings expectations over the past four quarters. BDX surpassed the consensus EPS estimate by a margin of 5.7% in the most recent quarter.
